Improved FDA Forensics Uncover More Manufacturing Data Integrity Issues
This article was originally published in PharmAsia News
Executive Summary
The US FDA learned how to find hidden information during its investigation of Ranbaxy, with techniques including improved forensic examinations of computers, and mock inspections are being held at some Indian and Chinese sites ahead of FDA visits.